Cargando…
Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
Autores principales: | Aggarwal, Anivita, Kodan, Parul, Gupta, Nitin, Ghosh, Sudeshna, Singh, Binit K., Jorwal, Pankaj, Nischal, Neeraj, Soneja, Manish, Wig, Naveet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586575/ https://www.ncbi.nlm.nih.gov/pubmed/33110896 http://dx.doi.org/10.4103/jfmpc.jfmpc_756_20 |
Ejemplares similares
-
Diagnostic Evaluation of Non-Interpretable Results Associated with rpoB Gene in Genotype MTBDRplus Ver 2.0
por: Singh, Binit Kumar, et al.
Publicado: (2020) -
2156. To Evaluate the Role of Kit-Based Loop-Mediated Isothermal Amplification (TB-LAMP) Assay in the Diagnosis of Tubercular Lymphadenitis
por: Nischal, Neeraj, et al.
Publicado: (2019) -
Human immunodeficiency virus infection with multiple opportunistic infections: lessons learnt from a non-adherent patient
por: Soneja, Manish, et al.
Publicado: (2021) -
Nontuberculous mycobacteria: A report of eighteen cases from a tertiary care center in India
por: Gupta, Nitin, et al.
Publicado: (2020) -
Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience
por: Aggarwal, Anivita, et al.
Publicado: (2022)